Pamplona Therapeutics and Coherent Biopharma today announced a strategic collaboration to combine Pamplona’s AI-driven targeted...
日前，同宜医药（苏州）有限公司与南京科络思生物科技有限公司在南京科络思生物总部签署全面战略合作协议。
同宜医药宣布已与 MultiValent Biotherapies, Inc.（以下简称“MultiValent”）就治疗前列腺癌的多肽类偶联药物 CBP-1018 达成独家许可协议。
Suzhou, China, February 21, 2025 — Coherent Biopharma (“Coherent”) announced that the U.S. Food and Drug Administration...
October 10, 2024 — Coherent Biopharma (“Coherent”) announced that the U.S. Food and Drug Administration (FDA) has grant...
On June 24, 2024, local time, the U.S. Food and Drug Administration (FDA) notified the approval of Orphan Drug Designation (ODD) f...